Abstract
Ophiophagus hannah has significant medical important among snakebite cases. The enzyme Phospholipase A2 (PLA2) is crucial for venom impacts in life-threatening symptoms. However, specific antivenom against this species remains under explored. This study aimed to analyze the potential of secondary metabolites from tamarind as PLA2 protein inhibitor specifically from Ophiophagus hannah venom using in-silico approaches. The sequences and three-dimensional structure of the PLA2 protein from O. hannah were physicochemicaly predicted using ProtParam. Virtual screening, drug-likeness, pharmacokinetic, and toxicity profiles of metabolite compound from Tamarind was performed using SwissADME. All ligands were downloaded from PubChem database. Molecular docking was carried out using PyRx and visualized using Discovery Studio 2016 software. All tamarind’s compounds are safe for long term administration because they displayed minimum risk for hepatotoxicity and AMES. The best interaction of secondary metabolites with PLA2 is owned by quercetin. Future in-vitro and in-vivo studies are needed to evaluate the use of secondary metabolite compounds as specific alternatives of antivenoms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
